The prognostic value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in patients with malignant pleural mesothelioma


Creative Commons License

YENİGÜN B. M., KAHYA Y., SOYDAL Ç., Tutkun N. A., KOCAMAN G., KOÇAK E. M., ...More

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.29, no.1, pp.93-101, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.5606/tgkdc.dergisi.2021.20432
  • Journal Name: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.93-101
  • Keywords: Computed tomography, malign mesothelioma, positron emission tomography, prognostic factor, thoracic surgery, METABOLIC TUMOR BURDEN, FDG-PET, F-18-FDG PET/CT, SURVIVAL, CHEMOTHERAPY, ASSOCIATION, MULTICENTER, VALIDATION, PREDICTION, EXPOSURE
  • Ankara University Affiliated: Yes

Abstract

Background: In this study, we aimed to investigate the prognostic value of metabolic F-18-fluorodeoxyglucose positron emission tomography/computed tomography parameters in malignant pleural mesothelioma patients.